Literature DB >> 15849840

Antinociceptive effect of botulinum toxin type a in rat model of carrageenan and capsaicin induced pain.

Lidija Bach-Rojecky1, Zdravko Lacković.   

Abstract

AIM: To test antinociceptive properties of botulinum toxin type A (BTX-A) in rats with carrageenan- and capsaicin-induced pain and inflammation.
METHODS: Pain was provoked with carrageenan (1%) or capsaicin (0.1%) injection into the plantar surface of the rat paw-pad. The effect of BTX-A 5 U/kg on carrageenan- and capsaicin-induced mechanical and thermal hypersensitivity, as well as the size of carrageenan-induced paw edema were tested 24 hours and 6 days following the toxin injection into the rat paw-pad. In the dose-response experiment, the effect of different doses of BTX-A (2, 3, 3.5, 5, and 7 U/kg) on carrageenan-induced mechanical hypersensitivity was investigated on day 5 after BTX-A application.
RESULTS: Pretreatment with 5 U/kg BTX-A significantly reduced or completely abolished the enhanced sensitivity to mechanical and thermal stimuli provoked by peripheral carrageenan or capsaicin injections. This reduction was significant when BTX-A was applied 6 days before the induction of pain and inflammation, but the toxin was ineffective when applied 24 hours before the challenge. In the dose-response experiment, the lowest effective dose was 3.5 U/kg, but apparently the effect was not dose-dependent. In contrast to the antinociceptive effect, 5 U/kg BTX-A had no effect on the carrageenan-induced paw edema.
CONCLUSION: The study demonstrated the efficacy of peripherally applied BTX-A pretreatment on the pain component of inflammatory process in experimental animals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15849840

Source DB:  PubMed          Journal:  Croat Med J        ISSN: 0353-9504            Impact factor:   1.351


  25 in total

1.  Comparison of analgesic effects of single versus repeated injection of botulinum toxin in orofacial formalin test in rats.

Authors:  Ivica Matak; Ivana Stracenski; Zdravko Lacković
Journal:  J Neural Transm (Vienna)       Date:  2012-06-17       Impact factor: 3.575

Review 2.  Evidence-based knee injections for the management of arthritis.

Authors:  Olivia T Cheng; Dmitri Souzdalnitski; Bruce Vrooman; Jianguo Cheng
Journal:  Pain Med       Date:  2012-05-23       Impact factor: 3.750

3.  The effect of sumatriptan on nitric oxide synthase enzyme production after iatrogenic inflammation in the brain stem of adolescent rats: A randomized, controlled, experimental study.

Authors:  Savas Demirpence; Semra Hiz Kurul; Müge Kiray; Kazim Tugyan; Osman Yilmaz; Galip Köse
Journal:  Curr Ther Res Clin Exp       Date:  2009-04

Review 4.  [Potential antinociceptive mechanisms of botulinum toxin].

Authors:  K R Aoki; J Francis; W H Jost
Journal:  Schmerz       Date:  2006-09       Impact factor: 1.107

5.  Blockade of glutamate release by botulinum neurotoxin type A in humans: a dermal microdialysis study.

Authors:  Larissa Bittencourt da Silva; Ali Karshenas; Flemming Winther Bach; Sten Rasmussen; Lars Arendt-Nielsen; Parisa Gazerani
Journal:  Pain Res Manag       Date:  2014 May-Jun       Impact factor: 3.037

6.  Effects of intraplantar botulinum toxin-B on carrageenan-induced changes in nociception and spinal phosphorylation of GluA1 and Akt.

Authors:  Shafaq Sikandar; Ynette Gustavsson; Marc J Marino; Anthony H Dickenson; Tony L Yaksh; Linda S Sorkin; Roshni Ramachandran
Journal:  Eur J Neurosci       Date:  2016-05-19       Impact factor: 3.386

7.  Botulinum toxin B in the sensory afferent: transmitter release, spinal activation, and pain behavior.

Authors:  Marc J Marino; Tetsuji Terashima; Joanne J Steinauer; Kelly A Eddinger; Tony L Yaksh; Qinghao Xu
Journal:  Pain       Date:  2013-12-11       Impact factor: 6.961

8.  Anti-inflammatory effects of botulinum toxin type a in a complete Freund's adjuvant-induced arthritic knee joint of hind leg on rat model.

Authors:  Ki Yeon Yoo; Hee Su Lee; Young Kyung Cho; You Sun Lim; Yi Seul Kim; Jung Hoi Koo; Se Jin Yoon; Jung Hwan Lee; Ki Hyo Jang; Sun Hong Song
Journal:  Neurotox Res       Date:  2013-12-12       Impact factor: 3.911

Review 9.  Therapeutic use of botulinum toxin in migraine: mechanisms of action.

Authors:  Roshni Ramachandran; Tony L Yaksh
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

10.  Botulinum toxin in migraine: Role of transport in trigemino-somatic and trigemino-vascular afferents.

Authors:  Roshni Ramachandran; Carmen Lam; Tony L Yaksh
Journal:  Neurobiol Dis       Date:  2015-05-06       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.